title: Pharmacology: defining the optimal dose of a new drug: a crucial decision.
authors.forename: Hiddo Lambers
authors.initials: HL
authors.lastname: Heerspink
authors.forename: Dick
authors.initials: D
authors.lastname: de Zeeuw
mesh_terms: D047228:Angiotensin II Type 1 Receptor Blockers / Q000008:administration & dosage*; D004305:Dose-Response Relationship, Drug; D015195:Drug Design; D006801:Humans; D007674:Kidney Diseases / Q000188:drug therapy* / Q000517:prevention & control*; D012084:Renin-Angiotensin System / Q000187:drug effects*
chemical_list: D047228:Angiotensin II Type 1 Receptor Blockers
references.citation: J Cardiovasc Pharmacol. 2003 Dec;42(6):752-6
references.pmid: 14639097
references.citation: Drugs. 1980 Dec;20(6):409-52
references.pmid: 7009133
references.citation: J Am Soc Nephrol. 2009 Apr;20(4):688-9
references.pmid: 19279124
references.citation: J Am Soc Nephrol. 2009 Mar;20(3):655-64
references.pmid: 19144760
references.citation: Kidney Int. 2004 Jun;65(6):2309-20
references.pmid: 15149345
references.citation: Diabetes. 1998 Mar;47(3):450-6
references.pmid: 9519753